Oxford Drug Design Limited
- Company number
- 04305857
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 17 Oct 2001
- Nature of business
- Research and experimental development on biotechnology
Registered office
Previous names
- Inhibox Limited (until 15 May 2017)
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| NAYLOR, Andrew James | Director | 25 Jun 2009 | 7 Jun 2012 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Mr Michael Underwood | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
6 Apr 2016 | 20 May 2019 |
| Ip2ipo Limited | Significant Influence Or Control | 6 Apr 2016 | 29 Jul 2019 |
| Ip Venture Fund (Gp) Limited | Significant Influence Or Control | 6 Apr 2016 | 29 Jul 2019 |
Accounts
| Year ended | Cash | Employees |
|---|---|---|
| 31 Dec 2025 | - | 7 |
| 31 Dec 2024 | £432,123 | 7 |
| 31 Dec 2023 | £543,456 | 8 |
| 31 Dec 2022 | £1,458,732 | 9 |
| 31 Dec 2021 | £297,292 | 8 |
| 31 Dec 2020 | £739,356 | 7 |
| 31 Dec 2019 | - | - |
| 31 Dec 2018 | - | - |
| 31 Dec 2017 | - | - |
| 31 Dec 2016 | - | - |
| 31 Dec 2015 | - | - |
| 31 Dec 2014 | - | - |
| 31 Dec 2013 | - | - |
| 31 Dec 2012 | - | - |
| 31 Dec 2011 | - | - |
| 31 Dec 2010 | - | - |
| 31 Dec 2009 | - | - |
| 31 Dec 2008 | - | - |
| 31 Dec 2007 | - | - |
| 31 Dec 2006 | - | - |
| 31 Dec 2005 | - | - |
| 31 Dec 2004 | - | - |
| 31 Dec 2003 | - | - |
| 31 Dec 2002 | - | - |
Connections
Companies at the same address
- Be Useful Ai Ltd (17297090)
- ETF Strategy Limited (07800778)
- Intelligent Connections Limited (12017109)
- Oxford Antibiotics Limited (10329705)
- Oxford Brain Diagnostics Ltd (11703979)
- Oxford Innovation Limited (02177191)
- Oxford Investment Opportunity Network Limited (07719853)
- SQW Group Limited (04947276)
- SQW Group Newco 2018 Ltd (11560281)
- SQW Limited (01701564)